Accordingly, when the percent of inhibition of cell activation was calculated, a significant lower suppressive capability of CD69+ cells from SLE patients was evident, compared to healthy subjects (p < 0.01, Figure 4(c)). This evidence concerns the gene CD69 and systemic lupus erythematosus.